VE202 clinical trials

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients with Mild-to-Moderate Ulcerative Colitis

This study is looking at a new medicine called VE202 for people with mild to moderate ulcerative colitis. It aims to see if VE202 can help improve the condition and if it's safe to use compared to a dummy medicine.